Literature DB >> 12766730

What did we learn from the OPTIMAAL trial? What can we expect from VALIANT?

Kenneth Dickstein.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12766730     DOI： 10.1016/S0002-8703(03)00168-6

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  2 in total

1.  One-year renal and cardiac effects of bisoprolol versus losartan in recently diagnosed hypertensive patients: a randomized, double-blind study.

Authors:  Gaspare Parrinello; Salvatore Paterna; Daniele Torres; Pietro Di Pasquale; Manuela Mezzero; Gabriella La Rocca; Mauro Cardillo; Caterina Trapanese; Mario Caradonna; Giuseppe Licata
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

Review 2.  Beta-blockers in heart failure: is more better?

Authors:  Lawrence Baruch; Prabhakara Kunamneni
Journal:  Curr Heart Fail Rep       Date:  2004-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.